TCF7L2 and type 2 diabetes mellitus: T2D patients carrying specific polymorphisms like rs7903146 and rs12255372 in the TCF7L2 gene have been observed to exhibit poor responses to sulfonylurea treatments, highlighting the potential for genetic screening in optimizing therapeutic approaches [45,46,47,48].